About
Cannabis Addiction/Psychosis Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
10
As Collaborator
2
Total Enrollment
779
By Phase
PHASE1/PHASE2: 2PHASE1: 6PHASE2: 2
By Status
COMPLETED: 7NOT_YET_RECRUITING: 2UNKNOWN: 2TERMINATED: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06678399Lead Sponsor
Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
PHASE1/PHASE2Not yet recruiting
91 participants
Started: Apr 1, 2025 · Completed: Jan 1, 2027
NCT06395688Lead Sponsor
Drug-Drug Interaction Between THC and AEF0117
PHASE1Not yet recruiting
24 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2025
NCT05451017Lead Sponsor
The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy Volunteers
PHASE1Terminated
24 participants
Started: Jan 4, 2023 · Completed: Jun 28, 2023
NCT05554926Lead Sponsor
Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects
PHASE1Completed
8 participants
Started: Dec 16, 2022 · Completed: Feb 24, 2023
NCT05748405Lead Sponsor
Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome
PHASE1/PHASE2Completed
40 participants
Started: Dec 15, 2022 · Completed: Oct 7, 2024
Locations (1)
Headquarters
Bordeaux, France
Map
Loading map...